Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators (Q42548784)
Jump to navigation
Jump to search
scientific article published on June 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators |
scientific article published on June 1997 |
Statements
1 reference
Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators (English)
1 reference
Teo KK
1 reference
Burton JR
1 reference
Buller C
1 reference
Plante S
1 reference
Yokoyama S
1 reference
Montague TJ
1 reference
1 June 1997
1 reference
1 reference
13
1 reference
6
1 reference
591-599
1 reference
Identifiers
1 reference